# Darifenacin

NDC: 69097-431
Generic name: Darifenacin Hydrobromide
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20160901

FDA application: ANDA207664

## Active ingredients

- DARIFENACIN HYDROBROMIDE: 7.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-431"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-431
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e8470d1-c3e6-4644-b70a-aa47ddf79676